Captrust Financial Advisors Ocular Therapeutix, Inc Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 16, 2022
BUY
$4.09 - $6.5 $4,090 - $6,500
1,000 Added 9.52%
11,500 $48,000
Q2 2022

Aug 16, 2022
BUY
$3.01 - $5.22 $30,099 - $52,200
10,000 Added 2000.0%
10,500 $42,000
Q2 2020

Aug 14, 2020
BUY
$4.67 - $8.95 $2,335 - $4,475
500 New
500 $4,000

Others Institutions Holding OCUL

# of Institutions
183
Shares Held
136M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $572M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email